Skip to main content

BioAdaptives, Inc.

corporate_fare Company Profile

BioAdaptives, Inc.

BDPT·OTC·Life Sciences·CIK 0001575142

BIOADAPTIVES, INC. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers several products, including MyndMed, which is designed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health. Another product is Zeranovia, a weight loss enhancer. Wynovia is provided to help reduce the loss of lean muscle mass during dieting. The company also offers Xcellara, described as a regenerative wellness solution. In addition to human-focused products, BIOADAPTIVES, INC. provides canine products under the PawPa brand and dog chew products under the Regen brand. The company also distributes the Lung Flute, which is a medical device. BIOADAPTIVES, INC. was incorporated in 2013 and is based in Las Vegas, Nevada. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013.

BioAdaptives, Inc. (OTC:BDPT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for BDPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for BDPT spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • BioAdaptives Q3: $5,144 Cash, Going-Concern Doubt, 223.7M Shares After Debt Conversions
  • Penny-Stock Nutraceutical Firm Buys Preclinical Psilocybin Biotech With Stock, No Cash
  • BioAdaptives to Acquire Xycota; Founders Get 40% Economics and Eventual 51% Voting Control
  • BioAdaptives Q2 10-Q: Going Concern, Cash Crunch, and Massive Dilution from Debt Conversions
  • BioAdaptives' MyndSystem™ Achieves Full WADA Compliance, Unlocking Pro Athlete Market

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$18.28K
Net Income
-$1.56M
Diluted EPS
-$0.15
Op. Cash Flow
-$516.02K
Free Cash Flow
-$534.02K
Gross Profit
$12.5K
Operating Income
-$1.04M
Cash & Equivalents
$215.21K
Debt / Equity
0.00×
Net Margin
-85.23×
Shares Outstanding
12.01M sh
Source: 10-K · filed 2026-04-14 · accession 0001640334-26-000718

Short Interest & Short Volume

On November 20, 2026, 98.8% of BDPT volume reported to FINRA trade-reporting facilities was marked short.

Daily short volume (FINRA facilities)98.8% of 496,332 shares on November 20, 2026
5-day average short volume59.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$0.0012 -4.00% today
52-week range · as of 2026-11-16 $0.0008 – $0.07
Market cap
$268.41K
Volume
496.3K (0.1× avg)
3-mo avg 6.1M
Live data · 2026-11-21 10:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BDPT - Latest Insights

BDPT
Nov 16, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0012
Real-time Price: $0.0012 info
Change: $0 (0%) info
Market Cap: $268.413K info
BDPT
Nov 05, 2026, 8:00 AM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.0016
Real-time Price: $0.0012 info
Change: -$0.0004 (-25%) info
Market Cap: $268.413K info
BDPT
Nov 04, 2026, 6:01 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0017
Real-time Price: $0.0012 info
Change: -$0.0005 (-29%) info
Market Cap: $268.413K info
BDPT
Aug 19, 2026, 11:49 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.00235
Real-time Price: $0.0012 info
Change: -$0.00115 (-49%) info
Market Cap: $268.413K info
BDPT
Jun 25, 2026, 2:48 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0057
Real-time Price: $0.0012 info
Change: -$0.0045 (-79%) info
Market Cap: $268.413K info
BDPT
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.011
Real-time Price: $0.0012 info
Change: -$0.0098 (-89%) info
Market Cap: $268.413K info
BDPT
May 15, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.011
Real-time Price: $0.0012 info
Change: -$0.0098 (-89%) info
Market Cap: $268.413K info
BDPT
Apr 14, 2026, 4:05 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.011
Real-time Price: $0.0012 info
Change: -$0.0098 (-89%) info
Market Cap: $268.413K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets